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ORIGINAL RESEARCHDNA Methylation Analysis Validates Organoids as a Viable Model
for Studying Human Intestinal Aging
Sophia K. Lewis,1,2 Daniel Nachun,3 Martin G. Martin,2,4 Steve Horvath,5 Giovanni Coppola,3,6
and D. Leanne Jones1,2
1Department of Molecular, Cell and Developmental Biology, 2Eli and Edythe Broad Stem Cell Research Center, 3Department of
Psychiatry and Semel Institute, 4Division of Gastroenterology and Nutrition, Department of Pediatrics, Mattel Children’s
Hospital and David Geffen School of Medicine, 6Department of Neurology, University of California Los Angeles, Los Angeles,
California; 5Department of Human Genetics, Gonda Research Center, David Geffen School of Medicine, Los Angeles, CaliforniaSUMMARY
We found that human intestinal organoids maintain the age
of the patient from whom they are derived, as measured by
the epigenetic clock. Unexpectedly, we found that crypts and
spheroids derived from small intestine showed striking
epigenetic age reduction, relative to the colon.
BACKGROUND & AIMS: The epithelia of the intestine and
colon turn over rapidly and are maintained by adult stem cells
at the base of crypts. Although the small intestine and colon
have distinct, well-characterized physiological functions, it
remains unclear if there are fundamental regional differences
in stem cell behavior or region-dependent degenerative
changes during aging. Mesenchyme-free organoids provide
useful tools for investigating intestinal stem cell biology
in vitro and have started to be used for investigating age-
related changes in stem cell function. However, it is un-
known whether organoids maintain hallmarks of age in the
absence of an aging niche. We tested whether stem
cell–enriched organoids preserved the DNA methylation-
based aging profiles associated with the tissues and crypts
from which they were derived.
METHODS: To address this, we used standard human
methylation arrays and the human epigenetic clock as abiomarker of age to analyze in vitro–derived, 3-dimensional,
stem cell–enriched intestinal organoids.
RESULTS: We found that human stem cell–enriched organoids
maintained segmental differences in methylation patterns and
that age, as measured by the epigenetic clock, also was main-
tained in vitro. Surprisingly, we found that stem cell–enriched
organoids derived from the small intestine showed striking
epigenetic age reduction relative to organoids derived from
colon.
CONCLUSIONS: Our data validate the use of organoids as a
model for studying human intestinal aging and introduce
methods that can be used when modeling aging or age-onset
diseases in vitro. (Cell Mol Gastroenterol Hepatol
2020;9:527–541; https://doi.org/10.1016/j.jcmgh.2019.11.013)
Keywords: Intestinal Stem Cells; Organoids; Epigenetic Clock;
Aging; DNA Methylation.
aintenance of the gut epithelium throughout lifeMrelies on tissue-specific stem cells that reside at
the base of invaginating crypts in both the small intestine (SI)
and colon. These intestinal stem cells (ISCs), marked by the
Wnt target gene Lgr5, rapidly divide to maintain the stem cell
population or differentiate to generate specialized absorptive
and secretory epithelial cells.1
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digestive functions, it remains unclear to what extent thereAbbreviations used in this paper: DNAm, age based on DNA methyl-
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during aging. The majority of data on stem cells in the
mammalian digestive tract are derived from studying the
mouse SI; however, a major caveat to using mice to inves-
tigate intestinal physiology relevant to human beings is
species-specific differences in regional biology.2 It is
imperative that we use reliable in vitro models to study
human gut stem cell behavior because human in vivo ana-
lyses generally are impractical. Three-dimensional organo-
ids, self-organizing cultures of ISCs, and their progeny have
transformed our ability to study human intestinal physi-
ology and stem cell function.3–6 Recent evidence has sug-
gested that organoids derived from human colon and
terminal ileum maintain region-specific DNA methylation
patterns and regional gene expression.7 In addition, mouse
colon organoids aged in vitro show global methylation
changes similar to those seen in the aging mouse colon.8
However, although there is potential for organoids to be
used as models for aging,9 the degree to which organoids
faithfully recapitulate aging has yet to be determined.
Within the human gastrointestinal tract, aging is asso-
ciated with altered motility, inflammation, barrier dysfunc-
tion, and an increased risk of colon cancer.10–12 It is unclear,
however, to what extent changes in stem cell function un-
derlie age-related functional changes, especially in human
beings. In the mouse SI, aging is associated with decreased
crypt repair after irradiation, decreasing ISC numbers,
slower contribution of Lgr5þ cells to the intestinal epithe-
lium as determined by in vivo fate-mapping experiments,
and decreased organoid-forming capacity in vitro.13–15 In
addition, decreased Wnt signaling in aged animals impaired
the ability of mouse ISCs to maintain homeostasis and
contributed to decreased organoid-forming capacity
in vitro.16,17 By contrast, dietary restriction, a lifespan
extending intervention, enhanced stem cell numbers and
improved regenerative capacity, whereas short-term fasting
enhances organoid formation in aged mice.14,18,19 These
data suggest that ISC behavior likely is impacted by the
aging process, but the molecular changes that occur with
age in human beings and how these vary from individual to
individual are unknown.
To address the impact of aging on human ISCs, we
wanted to confirm whether mesenchyme-free, 3-
dimensional organoid cultures maintain hallmarks of age
in the absence of an aging intestinal microenvironment.
There are many hallmarks of aging, including cellular
senescence, telomere shortening, DNA damage, and gene
expression and epigenetic changes.20 At the epigenetic level,
genome-wide DNA methylation changes are pervasive dur-
ing aging, with increased variability in methylation observed
over time—a process known as epigeneticdrift.21–24
Although many of the changes that occur with age are sto-
chastic and vary from individual to individual, the methyl-
ation status of a distinct subset of CpG sites in the genome is
tightly correlated with age, such that these sites can be used
as an epigenetic clock to accurately predict the age ofhuman tissues.25,26 In addition, epigenetic clocks can predict
lifespan.27 Although these epigenetic clocks show tight
correlations between chronological age and predicted age
based on DNA methylation across populations, over-
prediction and underprediction of age can be biologically
and clinically meaningful. For example, patients with condi-
tions associated with early onset of age-related clinical fea-
tures, such as Down syndrome, Werner syndrome, or human
immunodeficiency virus, showed a premature age advance-
ment according to the epigenetic clock.28–31 Conversely,
lifespan-extending perturbations such as dietary restriction
caused a decrease in the ticking rate of recently developed
epigenetic clocks for mice, indicating that the clock may
reflect a biologically relevant state of aging.32,33
Here, we use the pan-tissue epigenetic clock by Hor-
vath26 as a biomarker of aging to determine if human in-
testinal organoids derived from SI and colon are a viable
model for studying stem cell behavior during aging, given
the absence of an aging niche. We focused on the multitissue
estimator because it applies to developmental samples and
allows one to compare aging rates from different tissues and
cell types.26
We found that intestinal organoids from human SI and
colon have global methylation patterns and epigenetic ages
similar to the primary crypt cells from which they were
derived. Unexpectedly, however, we also observed a marked
decrease in the epigenetic aging rate in human SI, when
compared with colon, in both crypt epithelial cells and stem
cell–enriched organoids (hereafter referred to as spheroids).
Strikingly, the change in the rate of aging in the SI appears in
midlife. Taken together, using a well-established molecular
hallmark of age, our data show significant differences in the
human SI and colon, findings that are preserved in orga-
noids in vitro.
Results
Regional Differences in Methylation Patterns Are
Maintained In Vitro
To begin a comparison of the aging of the proximal and
distal regions of the human intestine, we assayed DNA
methylation patterns of the SI (duodenum and jejunum
segments) and colon. SI specimens were obtained from in-
dividuals aged 0–85 years, and colonic specimens were
collected from patients aged 0–80 years (Table 1). Genomic
DNA was isolated from the SI (n ¼ 14) and colonic (n ¼ 12)
mucosal segments, consisting of epithelium, lamina propria,
and muscularis mucosae, in addition to the stem
cell–containing crypts of the SI (n ¼ 18) and colon (n ¼ 18)
Table 1.Summary of Human Small Intestine and Colon Specimens for DNA Methylation Analysis
ID number Tissue type Cell type analyzed Reason for surgery Sex Age/age range, y
1 Fetal small intestine Mucosa Fetal abortion M 0
2 Duodenum Mucosa Unknown F 50–55
3 Duodenum Mucosa Unknown F 75–80
4 Duodenum Mucosa Unknown F 65–70
5 Jejunum Mucosa Developmental abnormality F 0–5
6 Duodenum Mucosa Unknown F 60–65
7 Duodenum Mucosa Unknown M 70–75
8 Duodenum Mucosa Inflammatory bowel disease F 17
9 Duodenum Mucosa Pancreatic cancer F 35–40
10 Jejunum Mucosa Organ donation F 68
11 Duodenum Mucosa Pancreatic mass F 16–20
12 Jejunum Mucosa Organ donation M 17
13 Jejunum Mucosa Organ donation M 35
14 Duodenum Mucosa Pancreatic cancer F 80–85
2 Duodenum Crypt Unknown F 50–55
3 Duodenum Crypt Unknown F 75–80
4 Duodenum Crypt Unknown F 65–70
5 Jejunum Crypt Developmental abnormality F 0–5
6 Duodenum Crypt Unknown F 60–65
9 Duodenum Crypt Pancreatic cancer F 35–40
10 Jejunum Crypt Organ donation F 68
11 Duodenum Crypt Pancreatic mass F 16–20
12 Jejunum Crypt Organ donation M 17
13 Jejunum Crypt Organ donation M 35
14 Duodenum Crypt Pancreatic cancer F 80–85
15 Duodenum Crypt Organ donation M 71
16 Duodenum Crypt Unknown M 55–60
17 Duodenum Crypt Unknown M 75–80
18 Duodenum Crypt Unknown F 65–70
19 Duodenum Crypt Unknown M 50–55
20 Duodenum Crypt Biliary stricture, pancreatic dysplasia M 55–60
21 Jejunum Crypt Organ donation M 47
10 Colon Mucosa Organ donation F 68
12 Colon Mucosa Organ donation M 17
13 Colon Mucosa Organ donation M 35
22 Colon Mucosa Unknown F 70–75
23 Colon Mucosa Unknown M 30–35
24 Colon Mucosa Colorectal cancer F 75–80
25 Colon Mucosa Diverticulitis F 65–70
26 Colon Mucosa Colorectal cancer F 65–70
27 Colon Mucosa Colorectal cancer F 70–75
28 Colon Mucosa Colorectal cancer M 70–75
29 Colon Mucosa Diverticulitis F 65–70
30 Colon Mucosa Unknown F 75–80
10 Colon Crypt Organ donation F 68
12 Colon Crypt Organ donation M 17
13 Colon Crypt Organ donation M 35
21 Colon Crypt Organ donation M 47
22 Colon Crypt Unknown F 70–75
24 Colon Crypt Colorectal cancer F 75–80
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Table 1.Continued
ID number Tissue type Cell type analyzed Reason for surgery Sex Age/age range, y
26 Colon Crypt Colorectal cancer F 65–70
27 Colon Crypt Colorectal cancer F 70–75
28 Colon Crypt Colorectal cancer M 70–75
29 Colon Crypt Diverticulitis F 65–70
31 Colon Crypt Unknown M 55–60
32 Colon Crypt Diverticulitis F 65–70
33 Colon Crypt Unknown F 75–80
34 Colon Crypt Developmental abnormality F 0.5
35 Colon Crypt Colorectal cancer M 61–65
36 Colon Crypt Colorectal cancer M 56–60
37 Colon Crypt Colorectal cancer M 51–55
38 Colon Crypt Colorectal cancer M 61–65
F, female; M, male.
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normal. Subsequently, genome-wide methylation was
assayed using commercially available methylation arrays
(see Materials and Methods section).
To determine whether regional differences in epigenetic
patterns are maintained in vitro for more proximal tissues,
we conducted differential methylation analysis of mucosa,
crypts, and spheroids from both the SI (duodenum and
jejunum) and colon.4,7,34 Spheroids are enriched for cells
harboring stem cell characteristics—they divide rapidly and
are capable of multilineage differentiation.4 Upon reduction
of Wnt3A and withdrawal of other growth factors, SI
spheroids change morphology to dense folded organoids,
stop dividing, down-regulate Lgr5, and begin to express
markers of mature absorptive and secretory lineages
(Figure 1B–E).
Principal component analysis (PCA) of promoter
methylation data from these samples showed clustering by
cell type, with separation of whole mucosa from crypts and
spheroids (Figure 2A). PCA analysis also showed separation
by tissue type, with SI clustering away from the colon
(Figure 2B). SI and colon spheroids grouped closer to iso-
lated crypts from the same region, although there were no
distinct clusters (Figure 2B). Pediatric and adult samples
showed similar behavior in PCA plots.
We also determined whether the differences in methyl-
ation levels between colon and SI spheroids were correlated
with the differences observed between colon and SI crypts.
These analyses showed a strong positive correlation be-
tween the log fold change values of these 2 comparisons,
providing additional evidence that the differences between
the colon and SI are maintained in vitro (Figure 2C).
Moreover, we correlated the log fold change values of all of
the pairwise comparisons with each other and observed 3
distinct clusters (Figure 2D). One cluster, as expected,
highlighted that tissue differences (SI vs colon) were
correlated across mucosa, crypts, and spheroids. A second
cluster emphasized methylation differences between mu-
cosa vs crypts, and a third cluster highlighted differencesbetween in vitro spheroids and primary crypts from both
organs. In other words, comparing spheroids with isolated
crypts from the same tissue showed a signature, an overall
change in methylation patterns, that results from deriving
in vitro cultures. Importantly, the changes in methylation
between crypts and spheroids were conserved between the
SI and colon, suggesting a possible, common in vitro
methylation signature (Figure 2D). Taken together, these
data show that regional differences in methylation patterns
are largely preserved in culture. These data comparing du-
odenum and jejunum with colon are consistent with recent
reports comparing primary tissues and organoids from the
terminal ileum and colon.7DNA Methylation Age Is Reduced in Crypts From
the Small Intestine
DNA methylation patterns change dynamically with
age.21,23 Having confirmed that spheroids derived and
maintained in vitro recapitulate regional differences in
methylation patterns, we wanted to determine whether SI
and colon cultures derived in vitro accurately reflect the age
of the tissue from which they were derived. Several algo-
rithms, referred to as epigenetic clocks, use DNA methylation
changes to predict chronological age for multiple species. By
using methylation array data sets from thousands of sam-
ples from >50 tissue and cell types, the Horvath26 epige-
netic clock identified 353 CpG sites that accurately estimate
age based on methylation levels across all reported human
cell and tissue types, except sperm. As such, the Horvath26
clock can be used as a biomarker of aging. Therefore, we
used the methylation status of 353 CpGs that comprise the
Horvath26 clock to calculate the predicted age based on DNA
methylation (DNAm age) of human SI (n ¼ 14) and colon
(n ¼ 12) mucosa, as well as isolated SI (n ¼ 18) and colon
(n ¼ 18) crypts (Table 1).
Across all samples, there was a linear relationship be-
tween chronological age and predicted DNAm age, as
Figure 1. Analysis of stem cell and differentiation markers in human intestinal spheroids. (A) Schematic of samples used.
Representative H&E-stained sections of mucosae shown. Scale bar: 100 mm. Mucosa, isolated crypts, and in vitro organoids
were used for methylation arrays for both human SI and colon. (B) Brightfield images of undifferentiated duodenal spheroids
(left) and differentiated spheroids (right). Scale bars: 200 mm. (C) Sixteen-hour 5-ethynyl-20-deoxyuridine incorporation in
whole-mount undifferentiated spheroids and spheroids after 4 days of differentiation. Note loss of proliferation upon differ-
entiation. Scale bar: 50 um. (D) Nitro-blue tetrazolium and 5-bromo-4-chloro-30-indolyphosphate NBT/BCIP intestinal alkaline
phosphatase (IAP) stain (purple) identifying enterocytes (left) and immunofluorescence staining for mucin-2 identifying Goblet
cells (right) on 5-mm sections of duodenal differentiated spheroids. Scale bars: 50 mm. (E) Quantitative polymerase chain re-
action for stem cell marker Lgr5 and enterocyte marker sucrase isomaltase in undifferentiated and differentiated spheroids
derived from n ¼ 3 duodenal specimens. Results are means ± SD. Samples were run in triplicate. Expression was normalized
to RPL13A transcript levels. Statistics: Student t test: *P < .05, ***P < .001. DAPI, 40,6-diamidino-2-phenylindole.
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Figure 2. Differential methylation analysis of human intestinal and colonic mucosa, crypts, and organoids. (A and B) PCA
of methylation at promoters. (A) PCA showing clustering by cell type (mucosa, crypts, spheroids). (B) PCA for cell and tissue type,
showing clustering by tissue (small intestine vs colon) and cell type (mucosa, crypts, spheroids). (C) Log-fold-change (logFC) plot
showing correlation of regional differences in methylation levels at CpG sites within promoters between crypts (x-axis)
and spheroids (y-axis). The biweight midcorrelation coefficient is 0.49. (D) Pairwise correlations between logFC values for the
9 comparisons used in differential methylation of promoters. Correlations were computed using biweight midcorrelation, a robust
alternative to Pearson correlation. Average-linked hierarchical clustering was used to create a clustering dendrogram from
Euclidean distances between each vector of pairwise correlations. diff, differentiated; PC, Principal Component.
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(P < .0001) (Figure 3A). We next examined the linear
relationship between predicted and chronological age for
each tissue and cell type separately. In SI, the correlation
coefficient was higher for mucosa (r ¼ 0.94; P < .0001) than
for crypts (r ¼ 0.86; P < .0001). In colon, the correlation
coefficient was similar for mucosa and crypts (r ¼ 0.96;
P < .0001; and r ¼ 0.95; P < .0001, respectively).
We then compared the DNAm ages of SI and colon mu-
cosa with that of crypts isolated from each organ bycalculating the absolute difference between DNAm age and
chronological age, a difference known as DNA age acceler-
ation or deceleration (Figure 3B). Remarkably, crypts iso-
lated from the SI showed a significant age deceleration
compared with surrounding mucosa (mean error, -18.5 vs
-3.4 y, respectively; P < 1.6  10-7). In addition, SI crypts
had a significant age deceleration when compared with that
seen for colon crypts (mean error, -18.5 vs -5.8 y, respec-
tively; P < 6.6  10-6). There was also a decreased epige-
netic age in colon crypts compared with whole colonic
2020 Intestinal Organoids Maintain Epigenetic Age 533mucosa (mean error, -5.8 vs þ3.1 y, respectively; P < 1.34 
10-4); however, the magnitude of this difference was smaller
than that detected for SI. We also observed that the SI
mucosa appeared to age more slowly than the colon mucosa
(mean error, -3.4 vs þ3.1, respectively; P < 5.3  10-3), but
the degree of age deceleration was smaller in SI mucosa, and
the colon mucosa actually showed mild age acceleration.
Taken together, these data indicate that the ticking rate of
the epigenetic clock for epithelial cells within SI crypts is
considerably slower than for either of the other cells con-
tained within the SI mucosa or cells within colonic crypts.
Small Intestine DNAm Aging Rate Slows in
Midlife
Although an apparent age deceleration was observed in SI
crypts, the ticking rate of the epigenetic clock in SI is in sync
with the chronological clock until middle age (approximately
40 years), when it begins to slow. Specifically, we found that
the degree of DNAm age deceleration in SI samples, crypts in
particular, increased with greater chronological age
(Figure 3C). There is a negative correlation between age
prediction error and chronological age for SI crypts (r ¼
-0.90; P < 1  10-4). A similar trend was seen in SI mucosa,
although to a lesser extent than in crypts (r ¼ -0.78; P ¼
.001). Although there was a negative correlation between
DNAm age prediction error and chronological age for both
colon crypts and mucosa (r ¼ -0.47; P ¼ .05; and r ¼ -0.69;
P ¼ .01, respectively), these were much less significant than
the trends noted in the SI. Taken together, these data suggest
that the ticking rate of the epigenetic clock is largely in sync
with the chronological clock through older age for colon, in
contrast to the age deceleration observed in the SI. Impor-
tantly, the age deceleration observed in the SI is not owing to
an inability of the clock to predict age for the SI.
DNA Methylation Age Deceleration for Small
Intestine Is Observed in Paired Intestinal Samples
To address the confounding factor of different underly-
ing medical histories in SI vs colon surgical samples and to
account for interindividual variation, we analyzed 4 paired
jejunum and transverse colon segments from organ donors
immediately post-mortem for DNAm age analysis. The pre-
dicted DNAm age of jejunum crypts was younger than the
DNAm age of paired colon crypts for all 3 older adult donors
(ages, 35, 47, and 68 years), consistent with our findings
that crypts isolated from the SI showed decreased epige-
netic aging rates when compared with colon crypts
(Figure 3D). By contrast, the 17-year-old donor showed
congruence between DNAm and chronological age for both
jejunum and colon.
Age and Sex Do Not Likely Contribute to Tissue
Differences in DNAm Age
DNAm aging profiles are influenced by sex, and the
epigenetic aging rate for women tends to be lower than
men, at least for blood cells.25,35 Given that we uncovered a
slowing in epigenetic aging for SI midlife (w40 years), itwas important to consider how males and females were
distributed between our younger (<40 year) and older
(>40 year) populations. Overall, for SI and colon crypt
samples, our samples included almost equal proportions of
male and female samples. Notably, this distribution did not
change dramatically after age 40 (Figure 3E), indicating that
sex is likely not a major contributing factor to the slowed
ticking rate of the epigenetic clock at middle age for SI
crypts. We also noted that there was no significant differ-
ence in the age distribution for mucosa and crypts from SI
and colon (Figure 3F).
To further characterize which variables were significant
predictors of DNA methylation, we fitted a linear mixed-
effects model to predict DNAm age as a function of chro-
nological age, sex, batch, tissue, and cell type. We found that
chronological age was a strong predictor of methylation age
(P < 3.14  10-16), as expected, whereas sex (P < .33) and
batch (P < .04) were not significant, using a strict cut-off
value of P < .01 for statistical significance. The combined
influence of tissue and cell type (ie, SI crypts, SI mucosa, and
so forth) were also a highly significant predictor of DNA
methylation age (P < 3.1  10-10).
By using our gene expression data, we then asked
whether changes in gene expression could provide insight
into the observed differences in chronological aging rates
between the SI and colon, as determined by the epigenetic
clock. We identified 3028 differentially expressed genes
between SI (n ¼ 16) and colon (n ¼ 6) crypts (false dis-
covery rate [FDR] < 0.01) (Figure 3G). Gene ontology
analysis showed the most striking differences in gene
expression between SI and colon crypts were related to
anion transport, epithelial differentiation, lipid transport
and metabolism, and intestinal absorption (Figure 3H),
likely reflecting functional differences between the 2 tissues.
However, this analysis did not show enrichment for any
previously characterized aging-associated genes.DNA Methylation Age Deceleration of Human
Small Intestine Is Maintained in Cultured
Spheroids
There is potential for organoids to be used as models for
aging9; however, whether in vitro culture conditions alter or
reset aging profiles for SI or colon, thereby minimizing
detection of age-associated functional changes, is not clear.
To determine if human ISCs cultured in vitro maintain
epigenetic aging profiles similar to cells found in primary
uncultured epithelial crypts, we compared the DNAm age of
duodenal and colonic crypts with their corresponding
spheroid cultures, analyzed at early passages (Figure4A andB).
Consistent with our previous data, duodenal spheroids
showed DNAm age deceleration similar to the crypts from
which they were derived, although there was a slightly
younger DNAm age in SI spheroids compared with crypts.
In colon, we found that spheroids also have a DNAm age
similar to the crypts from which they were derived, how-
ever, in contrast to SI, the DNAm ages of colon spheroids
and crypts were close to the chronological age of the donor.
Importantly, these data indicate that age, as measured by
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In addition, these results confirm regional differences in
epigenetic aging and suggest potential differences in ISC
aging, as reflected by DNAm, in closely related tissues.
DNA Methylation Age Does Not Change During
Differentiation In Vitro
To investigate whether the DNAm age, as reported by the
epigenetic clock, is altered during stem cell differentiation in
culture, we subjected duodenal spheroids to differentiation
conditions for 4 days (Figure 1B–E). We first analyzed the
global methylation pattern of differentiated cells and
compared them with the undifferentiated spheroids from
which they were derived. Differentiated cultures clustered
closely with stem cell–enriched spheroids from the same
tissue (Figure 2B). Similar to Kraiczy et al,7 we found no
differentially methylated regions (FDR <0.01) between SI-
derived stem cell–enriched spheroids (n ¼ 12) and differ-
entiated (n ¼ 4) organoids (Figure 4C), although our small
sample size and stringent statistical cut-off limited our
ability to detect subtle changes in methylation. Interestingly,
when stem cell–enriched spheroids from duodenum were
allowed to differentiate for 4 days in vitro, the observed
decreased epigenetic age was maintained (Figure 4D),
indicating that youthful progenitor cells may be responsible
for maintaining the lower epigenetic age of SI epithelium as
a whole. In addition, these data underscore the observation
that proliferation rates do not impact the epigenetic clock
significantly.26
Discussion
It is well known that lifestyle and environmental factors
can influence aging, and there is increasing interest in un-
derstanding the relationship between interindividual vari-
ability in aging rates and susceptibility to age-associated
pathologies, including cancer and neurodegenerative dis-
ease. In this study, we sought to determine whether human
SI and colon organoids can be used as reliable tools to
investigate stem cell–intrinsic aging in vitro. DNA
methylation-based age predictions now provide us with aFigure 3. (See previous page). Epigenetic clock analysis of hu
rate in crypt cells from the small intestine. (A) Scatter plot o
nological age (x-axis) for mucosa and crypts isolated from huma
0.84; P < .0001. (B) Plot of DNAm age deceleration (the absolu
mucosa and crypts isolated from SI and colon. Data are presente
effects model: **P < .01, ***P < .001, ****P < .0001. (C) Relat
difference between DNAm age and chronological age (y-axis). N
crypts. (D) DNAm-based age prediction (y-axis) for paired jejunu
indicates an individual’s chronological age. Data points als
(E) Venn diagrams show distributions of males and females a
Proportions of each gender in all samples (top); proportions of e
(F) Plot of chronological age for samples used for epigenetic age
(G) Differential gene expression between SI and colon crypts. Th
-log10 P value of differential expression. Blue dots show genes
genes that were not significantly different. A total of 3028 differen
pathway analysis of the 3028 genes expressed differentially betw
P value of the overlap between up-regulated and down-regulate
axis. The vertical line is the significance cut-off value at P < .0tool to quantify aging rates across individuals and between
tissue types.25,26,36 The Horvath26 multitissue epigenetic
clock shows tight linear correlations between DNAm age
and chronological age across tissues. However, some tissues,
such as cerebellum, show a decreased DNAm aging rate,
while other organs, such as breast, show an increased
DNAm aging rate, indicating that not all tissues within the
same individual age similarly.26,37,38
Although previous studies have indicated that regional
DNA methylation patterns and gene expression are main-
tained in intestinal organoids,7,39,40 it was not obvious that
the methylation status of sites used for age estimation
would be unchanged in vitro. Although there was a slight
epigenetic age reduction in SI spheroids compared with SI
crypts, our data suggest that in vitro stem-like spheroids
largely show DNAm aging rates similar to the crypts from
which they were derived. In addition, we observed that
DNAm age is preserved during differentiation because there
were no significant differences between highly proliferative
stem cell–containing spheroids and differentiating organo-
ids containing nonproliferating cells, further supporting the
notion that epigenetic clocks do not simply reflect differ-
ences in cell division rates.26 Therefore, our data establish
that intestinal organoids are valid models for studying stem
cell–intrinsic aging, even in the absence of a mesenchymal
niche. Importantly, our data indicate that epigenetic clocks
can be a useful tool for assessing the degree to which in-
testinal diseases, particularly those with a strong inflam-
matory component, correlate with acceleration of aging
hallmarks.41
Our data also suggest fundamental differences in SI vs
colonic DNAm aging profiles, at least within epithelial cells
of the crypts, which is surprising given the similarities
shared between the SI and colon. Specifically, we found that
the correlation between DNAm and chronological age is
lower in SI crypts compared with SI mucosa, while DNAm
and chronological age are highly correlated for both crypts
and mucosa in colon. Interestingly, the difference between
DNAm age in SI crypts and mucosa is enhanced after midlife.
The ticking rate of the epigenetic clock for epithelial cells
within SI crypts is considerably slower than for cells withinman small intestine and colon shows a decreased ticking
f DNAm age based on the epigenetic clock (y-axis), vs chro-
n small intestine and colon. Pearson correlation coefficient ¼
te difference between DNAm age and chronological age) for
d as means ± SD. Statistics were derived from a linear mixed-
ionship between chronological age (x-axis) and the absolute
ote the age-dependent increase in DNAm deceleration for SI
m and transverse colon crypts from 4 individuals. Dotted line
o were included in the cumulative analysis in panel C.
mong crypt specimens used for epigenetic aging analysis.
ach sex in the samples from those older than age 40 (bottom).
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Figure 4. DNA methylation age deceleration of human small intestine is maintained in cultured spheroids and during
differentiation. (A) The difference between DNAm age and chronological age for paired crypts and spheroids derived from
duodenum and colon. Dotted lines indicate paired samples isolated from the same individual. Statistics were derived from the
nonparametric paired Wilcoxon signed-rank test. (B) Passage number of SI vs colon spheroids used for DNAm aging analysis.
Data are represented as means ± SD. (C) Volcano plot for differential methylation analysis identifies zero differentially
methylated promoters (FDR < 0.01) between duodenal stem cell–enriched spheroids and differentiated cultures. X-axis in-
dicates log fold change, the y-axis indicates the log P value. (D) The difference between DNAm age and chronological age for
paired duodenal stem cell–enriched and differentiated spheroids derived from the same sample (n ¼ 4). Dotted line indicates
paired samples. Statistics were derived from the nonparametric paired Wilcoxon signed-rank test. *P < .05.
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same person. The magnitude of the DNAm age reduction we
observed for the SI is considerably larger than that reported
previously for other tissues, providing a striking example of
an organ for which DNAm age diverges from chronological
age in an age-dependent fashion.26,37,38 Given that the effect
of cell composition on DNAm age prediction has been shown
to be minimal,26,42 we do not expect variation in the
composition of epithelial cells with age to explain the
observed differences in DNAm age between SI and colon
crypts. Unfortunately, differential gene expression analysis
could not explain the differences in DNAm aging between SI
and colon, although our analysis was limited by small
sample size. That being said, there are limited data in mouse
and rat models to suggest more robust expression of
metabolism-associated genes, immune response, and in-
flammatory genes in colon compared with SI during aging,
which suggest that gene expression changes with age may
differ by region, although further investigation in human
samples is necessary.43,44Much of what we know about ISC behavior comes from
studies in the SI, particularly in mice, and little is known
about how ISCs in the human colon compare with those
from the SI, especially during aging. Recent findings have
highlighted age-related changes in the mammalian intestine
and have begun to address the role stem cells may play in
functional decline.14–17 Specifically, ISCs from mouse, and
potentially human beings, show a decrease in regenerative
capacity as a result of decreased Wnt signaling.16,17 Our data
suggest that human SI and colon crypt cells differ with
respect to epigenetic age; however, whether this is physio-
logically relevant, as determined by functional changes with
age, remains to be tested. Although a comparison of age-
related changes in ISCs from the SI and colon using orga-
noids is theoretically feasible, colonic spheroids are
consistently less proliferative and less robust than SI-
derived cultures when grown under identical conditions
(S.L. and D.L.J., unpublished data). Therefore, interpretation
of experiments comparing growth and differentiation of SI
and colon spheroids from young and old patients may be
2020 Intestinal Organoids Maintain Epigenetic Age 537limited by intrinsic regional differences in stem cell func-
tion45 and preclude a direct comparison of the effects of
aging on SI and colon stem cell behavior. However, based on
our current results, we predict that age-related functional
changes in human colon stem cells will be more dramatic
than any detected for SI stem cells. Our findings lay the
foundation for characterizing such functional differences in
human SI and colon stem cells, which may eventually shed
light on the differences in the incidence of age-associated
diseases between these 2 organs, including adenocarcinoma.Materials and Methods
Experimental Procedures
Human bowel tissue. De-identified and discarded surgi-
cal specimens were retrieved from the University of California
Los Angeles Translational Pathology Core Laboratory (TPCL).
After clinical surgical pathology evaluation, normal adjacent
tissue was obtained. Experimentation using TPCL-derived hu-
man tissues was approved by the University of California Los
Angeles Institutional Review Board, which waived the informed
consent requirement for specimens acquired from the TPCL
(IRB 11-002504). The age of the human specimen was pro-
vided as a 5-year age range, according to TPCL practices.
Procurement of paired jejunum and colon from anonymous
post-mortem donors was facilitated by the OneLegacy Foun-
dation (Los Angeles, CA). Samples are summarized in Table 1.
Intestinal mucosa and crypt isolation. Tissues were
washed in phosphate-buffered saline (PBS), and mucosa was
isolated by removal of outer muscle layers using surgical
scissors. Mucosae were cut into 1-cm pieces and washed with
PBS until the supernatant was clear. Small intestine and
colonic crypts were isolated using modified existing
methods.4,6 Specimens were incubated at 4C in 8 mmol/L
EDTA and 1 mmol/L dithiothreitol for 30 minutes to 1 hour,
with gentle agitation. Supernatant was removed and replaced
with fresh PBS. Specimens were vortexed to release crypts.
Crypts were collected into 15-mL tubes and the process was
repeated to collect 4–6 fractions. Fractions were centrifuged at
100  g to pellet crypts. SI crypts subsequently were filtered
with 100-um mesh to remove villus domains and epithelial
debris. Isolated crypts were resuspended in basic medium
containing Advanced Dulbecco’s Modified Eagle Medium/F12,
1 Glutamax, 10 mmol/L HEPES buffer, and 1 penicillin/
streptomycin (all ThermoFisher Scientific, Waltham, MA) for
spheroid cultures, or resuspended in PBS for DNA lysis.
Genomic DNA Extraction
Duodenal and colonic mucosal specimens were chopped
into 5-mm pieces and homogenized; crypts were isolated as
described earlier. Homogenized mucosa and isolated crypts
were lysed and genomic DNA was isolated using standard
phenol–chloroform extraction with ethanol precipitation.
DNA was stored at -20C before downstream processing.
Bisulfite Conversion and Methylation Arrays
Bisulfite conversion of 500 ng DNA per sample
was conducted using the EZ-96 DNA MethylationGold Kit (Zymo Research, Irvine, CA). Samples subse-
quently were processed for Illumina (San Diego, CA)
HumanMethylation450 BeadChips and Infinium Methyl-
ationEPIC arrays according to the manufacturers’ in-
struction, and specimens were randomized across arrays.
Methylation status was reported as the b value (range,
0–1, with 0 ¼ unmethylated and 1 ¼ fully methylated). For
differential methylation analysis and principle component
analysis the M value was used.46Differential Methylation Analysis
Array preprocessing was run with the RnBeads pack-
age.47 Probes outside CpG contexts, on sex chromosomes, or
in single-nucleotide polymorphisms or with missing values
were removed. The greedycut algorithm in RnBeads was
used to remove probes with low detection score P values,
and probes with a SD less than 0.005 also were removed.
Only probes shared between the HumanMethylation450K
and HumanMethylationEPIC chips were retained. Back-
ground correction was performed with the out-of-band
method implemented by ENMix (National Institute of
Environmental Health Sciences, Research Triangle Park,
NC),48 and arrays were normalized using b mixture quantile
dilation (BMIQ).49 b values were averaged across promoters
(1.5 kb before transcription start site to 0.5 kb after the
transcription start site), gene bodies, or CpG islands and
converted to M values. M values were corrected for batch
effect using the parametric empiric Bayes method from
ComBat.50 Differential methylation was assessed using
linear modeling with the limma package,51 with age and sex
included as covariates, and a cut-off FDR of <0.01 was used
to determine significance.DNA Methylation Age Analysis Using the
Epigenetic Clock
After standard quality control, all samples were sub-
mitted to the epigenetic clock software,26 and the predicted
DNA methylation age was compared with the chronological
age for each sample. For each tissue sample for which the
precise age of the donor was not given, the midpoint of the
5-year age range was assigned as the chronological age. Age
correlation was calculated using the Pearson correlation
coefficient between chronological age and predicted DNAm
age. DNAm age acceleration/deceleration was calculated as
the absolute difference between chronological age and
DNAm age and was analyzed using a linear mixed-effects
model with a random effect for patient ID to account for
multiple samples coming from the same individuals. Paired
analysis was conducted using the paired Wilcoxon rank-sum
test.RNA Extraction and Gene Expression Microarray
Analysis
Samples were homogenized and lysed in TRIzol (Invi-
trogen, Carlsbad, CA) and RNA was isolated using the RNA
Clean and Concentrator kit (Zymo Research, Irvine, CA).
RNA integrity was analyzed on the Agilent 2200 TapeStation
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7.0 was used as a quality control threshold for RNA quality.
Gene expression was quantified on Illumina HT12 v4
microarrays and were preprocessed using the lumi pipeline
(Robert H. Lurie Comprehensive Cancer Center, Chicago,
IL).52 Expression values were normalized using the
variance-stabilized transformation,53 and robust spline
normalization was used for interarray normalization.
Probes with a detection score P value greater than .01 were
dropped, as were probes that were unannotated. Duplicated
probes for the same transcript were dropped using the
collapseRows function54 from the WGCNA package
(Department of Human Genetics, UCLA, Los Angeles, CA).
Differential expression was performed using limma,51 with
age and sex included as covariates. Gene ontology enrich-
ment was assessed using Enrichr (Department of Pharma-
cology and Systems Therapeutics, Icahn School of Medicine
at Mount Sinai, New York, NY).55
In Vitro Organoid Cultures
To generate cystic 3-dimensional spheroids, isolated
crypts were seeded at 150 crypts/25 uL of Growth Factor
Reduced Matrigel (356231; BD Biosciences, San Jose, CA) in a
48-well plate. Matrigel was allowed to solidify for 15 minutes
at 37C. Cells were overlaid with 250 uL of slightly modified
stem cell media,4,6 consisting of 50% Wnt3A conditioned
medium (see later), 50% Advanced Dulbecco’s Modified Ea-
gle Medium/F12, 1 penicillin/streptomycin, 1 Glutamax,
10 mmol/L HEPES, 1 mmol/L N-acetyl-L-cysteine (A9165;
Sigma, St. Louis, MO), 1 N2 supplement (17502; Life
Technologies, Carlsbad, CA), 1 B27 minus VitA (12587; Life
Technologies), 50 ng/mL epidermal growth factor (316-09;
Peprotech), 1 ug/mL human R-spondin (4645-RS; R&D,
Minneapolis, MN), 100 ng/mL murine noggin (250-38;
Peprotech, Rocky Hill, NJ), 10 mmol/L nicotinamide (N0636;
Sigma), 10 nmol/L gastrin (G9145; Sigma), 10 umol/L
SB202190 (S7067; Sigma), and 100 nmol/L prostaglandin E2
(P5640; Sigma). Medium was changed every 2–3 days.
Spheroids were passaged every 5–7 days by dissociation for
3 minutes in TrypLE Express (Life Technologies) at 37C
followed by reseeding in Matrigel. For 2 days after splitting,
10 umol/L Rock inhibitor Y27632 (Sigma) was added to the
medium. To trigger differentiation of cells within SI spher-
oids, nicotinamide, SB202190, and PGE2 were withdrawn;
Wnt3A conditioned medium was reduced to 10%; and 10
umol/L DAPT g secretase inhibitor (D5942; Sigma) was
added for 4 days of differentiation.4 Brightfield images of
organoids were acquired using the Zeiss AxioVert A1 TL/RL
microscope with the AxioCam MRm camera. Images were
analyzed using ZEN software (Zeiss, Oberkochen, Germany).
Wnt3A Conditioned Medium
L Wnt-3A cells (CRL-2647; American Type Culture
Collection, Manassas, VA) were cultured until 80%–90%
confluence in Dulbecco’s modified Eagle medium þ 10%
fetal bovine serum þ 1 penicillin/streptomycin. Cells then
were split to approximately 10% density and cultured for 4
days in t75 flasks. Day 4 supernatant was sterile-filtered.Fresh medium was replaced for 3 more days. Day 7 su-
pernatant was sterile-filtered, and combined with day 4
medium.4 Aliquoted stocks were stored at -20C.
5-Ethynyl-2’-Deoxyuridine Labeling
Spheroids were split to chamber slides (62407-355;
ThermoFisher Scientific) in stem cell medium containing
Y27632 (Y0503; Sigma). Ethynyl-2’-deoxyuridine labeling
was performed using the Click-iT ethynyl-2’-deoxyuridine
Alexa 594 Imaging Kit (C10339; Invitrogen). For prolifera-
tion analysis in stem cell vs differentiation conditions: 2
days after splitting, half of the wells were changed to dif-
ferentiation medium, as described earlier, and half were
maintained in stem cell medium. Cells were treated with 50
umol/L ethynyl-2’-deoxyuridine for the last 16 hours before
fixation.34 Organoids were fixed in 4% paraformaldehyde
and the Click-iT reaction was conducted according to the
manufacturer’s protocols. Samples were mounted in Vecta-
shield with 40,6-diamidino-2-phenylindole (H-1200; Vector
Laboratories, Burlingame, CA) to mark nuclei.Histologic Analysis and Immunofluorescence
Staining
Organoids were fixed in 5% neutral buffered formalin
for 30 minutes, embedded in HistoGel specimen processing
gel (HG-4000-012; ThermoFisher Scientific) before embed-
ding in paraffin, and sectioned at 5 um. Intestinal alkaline
phosphatase was detected using nitroblue tetrazolium
chloride 5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP)
according to published methods.56 For immunostaining on
paraffin sections, slides were dewaxed in xylene, rehy-
drated, and heat-mediated antigen retrieval was conducted
with citrate buffer (pH 6). For Goblet cells, sections were
immunostained with mucin-2 primary antibody (sc-15334,
1:50 dilution; Santa Cruz Biotechnology, Dallas, TX). Sec-
ondary staining was conducted with Alexa 568 goat anti-
rabbit IgG (A-11011, 1:1000 dilution; ThermoFisher Scien-
tific). Samples were mounted in Vectashield with 40,6-
diamidino-2-phenylindole (H-1200; Vector Laboratories) to
mark nuclei. Images were acquired using the Zeiss Axio
Observer.Z1 microscope with Apotome, with an AxioCam
503 mono camera (Zeiss). Images were analyzed using ZEN
software.
Reverse Transcription and Quantitative
Polymerase Chain Reaction
To isolate total RNA, samples were lysed in TRIzol re-
agent (15596026; Invitrogen), followed by chloroform
extraction and isopropanol precipitation. RNA was DNase-
treated and reverse-transcribed to complementary DNA
using the iScript Reverse Transcription Supermix
(15596026; Bio-Rad, Hercules, CA). Quantitative reverse-
transcription polymerase chain reaction was conducted
using SSO Advanced Universal SYBR Green Supermix (Bio-
Rad) and gene-specific primers (see the oligonucleotide
primers used were as follows:). Data were obtained on the
CFX96 Real Time System (Bio-Rad) using manufacturer
2020 Intestinal Organoids Maintain Epigenetic Age 539recommended device settings. Samples were analyzed in
triplicate. The human ribosomal gene RPL13A was used as
reference for quantification of gene expression. Fold-change
of messenger RNA expression between undifferentiated
spheroids and differentiated organoids was calculated using
the delta delta Ct method. The oligonucleotide primers used
were as follows: RPL13A, 5’-GCCCTACGACAAGAAAAAGCG-3’
(forward)/5’-TACTTCCAGCCAACC TCGTGA-3’ (reverse);
Lgr5, 5’-ACCAGACTATGCCTTTGGAAAC-3’ (forward)/5’-
TTCCCAGGGAGTGGATTCTAT-3’ (reverse); and sucrase
isomaltase, 5’- TTTTGGCATCCAGATTCGAC-3’ (forward)/5’-
ATCCAGGCAGCCAAGAATC-3’ (reverse).Data Availability
Genome-wide data has been deposited in Gene Expres-
sion Omnibus (GEO) with the following accession numbers:
GSE141254 (DNA methylation) and GSE141255
(expression).
All authors had access to the study data and reviewed
and approved the final manuscript.References
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